Your browser doesn't support javascript.
loading
The RareCyte® platform for next-generation analysis of circulating tumor cells.
Kaldjian, Eric P; Ramirez, Arturo B; Sun, Yao; Campton, Daniel E; Werbin, Jeffrey L; Varshavskaya, Paulina; Quarre, Steven; George, Tad; Madan, Anup; Blau, C Anthony; Seubert, Ronald.
Afiliação
  • Kaldjian EP; RareCyte, Inc., Seattle, Washington, USA.
  • Ramirez AB; RareCyte, Inc., Seattle, Washington, USA.
  • Sun Y; RareCyte, Inc., Seattle, Washington, USA.
  • Campton DE; RareCyte, Inc., Seattle, Washington, USA.
  • Werbin JL; RareCyte, Inc., Seattle, Washington, USA.
  • Varshavskaya P; RareCyte, Inc., Seattle, Washington, USA.
  • Quarre S; RareCyte, Inc., Seattle, Washington, USA.
  • George T; RareCyte, Inc., Seattle, Washington, USA.
  • Madan A; Covance Genomics, Redmond, Washington, USA.
  • Blau CA; Center for Cancer Innovation, University of Washington, Seattle, Washington, USA.
  • Seubert R; RareCyte, Inc., Seattle, Washington, USA.
Cytometry A ; 93(12): 1220-1225, 2018 12.
Article em En | MEDLINE | ID: mdl-30277660
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Neoplásicas Circulantes / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Neoplásicas Circulantes / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article